Unclaimed Scholar Profile
Are you Alane Izu? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-9128-2630-2919 orcid.org/0000-0002-5547-7223
Alane Izu
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Bacterial Infections and Vaccines#Neonatal and Maternal Infections#SARS-CoV-2 and COVID-19 Research#Pneumonia and Respiratory Infections
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 9,022 | 4,331 |
| h-index | 26 | 20 |
| i10-index | 55 | 39 |
Annual Citation Growth
Verified Citations / Year0
2020433
2021+40%606
2022+29%780
2023+33%1.0k
2024-8%953
2025-45%520
2026Scholarship Distribution & Proportions109 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (7,398) • 18% Global Research Impact (1,624)
109 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (109)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Published in New England Journal of Medicine•2023
DOI: 10.1056/nejmoa2116045 Verified Peer-Reviewed
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
Published in The Lancet HIV•2021
DOI: 10.1016/s2352-3018(21)00157-0 Verified Peer-Reviewed
Showing 1 – 5 of 109 publications
1 / 22